Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.9901
-0.0899 (-8.32%)
At close: Mar 3, 2026, 4:00 PM EST
0.9999
+0.0098 (0.99%)
After-hours: Mar 3, 2026, 7:35 PM EST
Curis Employees
Curis had 34 employees as of December 31, 2024. The number of employees decreased by 15 or -30.61% compared to the previous year.
Employees
34
Change (1Y)
-15
Growth (1Y)
-30.61%
Revenue / Employee
$342,647
Profits / Employee
-$1,075,176
Market Cap
13.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 34 | -15 | -30.61% |
| Dec 31, 2023 | 49 | -2 | -3.92% |
| Dec 31, 2022 | 51 | -9 | -15.00% |
| Dec 31, 2021 | 60 | 32 | 114.29% |
| Dec 31, 2020 | 28 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| CytoMed Therapeutics | 43 |
| BioLineRx | 28 |
| BioCardia | 20 |
| Quantum BioPharma | 17 |
| NewcelX | 15 |
| Cocrystal Pharma | 11 |
| Traws Pharma | 7 |
CRIS News
- 7 weeks ago - Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PRNewsWire
- 7 weeks ago - Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - PRNewsWire
- 3 months ago - Curis Provides Updated Data from its Frontline AML Triplet Study - PRNewsWire
- 3 months ago - Curis to Present at Upcoming 30th Annual SNO Meeting - PRNewsWire
- 4 months ago - Curis, Inc. (CRIS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Curis Provides Third Quarter 2025 Business Update - PRNewsWire
- 4 months ago - Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 - PRNewsWire
- 5 months ago - Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire